Biohaven (BHVN) Competitors

Viatris (NASDAQ:VTRS) and Biohaven (NYSE:BHVN) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their risk, analyst recommendations, valuation, profitability, community ranking, earnings, institutional ownership, media sentiment and dividends.

Is VTRS or BHVN more profitable?

Biohaven has a net margin of 0.00% compared to Viatris' net margin of -5.87%. Viatris' return on equity of 16.46% beat Biohaven's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Viatris	-5.87%	16.46%	7.09%
Biohaven	N/A	-225.12%	-158.89%

Which has more volatility & risk, VTRS or BHVN?

Viatris has a beta of 0.92, suggesting that its share price is 8% less volatile than the S&P 500. Comparatively, Biohaven has a beta of 1.27, suggesting that its share price is 27% more volatile than the S&P 500.

Do insiders & institutionals believe in VTRS or BHVN?

79.9% of Viatris shares are held by institutional investors. Comparatively, 88.8% of Biohaven shares are held by institutional investors. 0.1% of Viatris shares are held by insiders. Comparatively, 16.0% of Biohaven shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Do analysts rate VTRS or BHVN?

Viatris presently has a consensus price target of $10.50, suggesting a potential upside of 12.90%. Biohaven has a consensus price target of $63.15, suggesting a potential upside of 103.94%. Given Biohaven's stronger consensus rating and higher probable upside, analysts plainly believe Biohaven is more favorable than Viatris.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Viatris	2 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	1.75
Biohaven	0 Sell rating(s)	0 Hold rating(s)	14 Buy rating(s)	1 Strong Buy rating(s)	3.07

Which has higher valuation and earnings, VTRS or BHVN?

Viatris has higher revenue and earnings than Biohaven. Viatris is trading at a lower price-to-earnings ratio than Biohaven, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Viatris	$14.74B	0.75	$54.70M	-$0.53	-17.55
Biohaven	N/A	N/A	-$408.17M	-$9.39	-3.30

Does the MarketBeat Community prefer VTRS or BHVN?

Biohaven received 383 more outperform votes than Viatris when rated by MarketBeat users. Likewise, 67.44% of users gave Biohaven an outperform vote while only 34.85% of users gave Viatris an outperform vote.

Company	Underperform	Outperform
Viatris	Outperform Votes 23 34.85%	Underperform Votes 43 65.15%
Biohaven	Outperform Votes 406 67.44%	Underperform Votes 196 32.56%

Does the media refer more to VTRS or BHVN?

In the previous week, Viatris had 8 more articles in the media than Biohaven. MarketBeat recorded 13 mentions for Viatris and 5 mentions for Biohaven. Biohaven's average media sentiment score of 0.59 beat Viatris' score of -0.03 indicating that Biohaven is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Viatris	0 Very Positive mention(s)	2 Positive mention(s)	9 Neutral mention(s)	0 Negative mention(s)	2 Very Negative mention(s)	Neutral
Biohaven	5 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Biohaven beats Viatris on 12 of the 18 factors compared between the two stocks.